Fig. 1From: Androgen deprivation therapy improves the in vitro capacity of high-density lipoprotein (HDL) to receive cholesterol and other lipids in patients with prostate carcinomaIn vitro transfers of unesterified and esterified cholesterol, triglycerides and phospholipids from the donor lipid nanoemulsion to HDL (high density lipoprotein) of patients with prostate cancer before and after androgen deprivation therapy (n = 16). * p < 0.05, ** p < 0.01, *** p < 0.001 post-treatment vs basalBack to article page